Loading…
Reported covered position: Fl. Commissioner of Agriculture Nikki Fried, March 2019- October 2022 Charlie Crist, January 2017-Feburary 2019 Patrick E. Murphy, January 2013-December 2016 Lois Frankel, February 2015-September 2015 Alcee L. Hastings, July 2010-December 2013
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
SAFE Banking Act of 2023
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
SAFE Banking Act of 2023
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CANNABIS FINNANCIAL INDUSTRY GROUP via THE LIAISON GROUP, LLC
2025 · second_quarter · Q2
Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANNABIS FINNANCIAL INDUSTRY GROUP via THE LIAISON GROUP, LLC
2025 · first_quarter · Q1
Source: Senate LDA
SAFE Banking Act of 2023
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Ensuring cannabis businesses have access to financial services (SAFE Banking Act HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
SAFE Banking Act of 2023
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (SAFE Banking Act HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (SAFE Banking Act HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
SAFE Banking Act of 2023
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
SAFE Banking Act of 2023
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions, The SAFER Banking Act S. 2860
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
SAFE Banking Act of 2021
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
SAFE Banking Act of 2021
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
The National Cannabis Rountable supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. NCR's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA), America COMPETES bill, the end of year omnibus bill and other legislative vehicles. NCR also was active on the CLIMB Act (H.R. 8200), a bill that provides safe harbors for financial institutions, government programs, and capital markets. NCR discussed this concept with Senate offices but no Senate companion bill was introduced. NCR further discussed a SAFE "Plus" with House and Senate leadership which include language relating to expungements and provisions relating to firearm ownership for state authorized medical cannabis patients.
Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
Marijuana Opportunity Reinvestment and Expungement Act
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Marijuana Misdemeanor Expungement Bill (H.R. 8557). NCR has also supported comprehensive cannabis reform efforts as they develop in the Senate. NCR met with the White House on cannabis clemency issues, specifically pardons for non-violent offenders, a process for post-conviction release and calling for a reclassification of cannabis.
Philippine Human Rights Act
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
Medical Marijuana Research Act
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
Harnessing Opportunities by Pursuing Expungement Act of 2021
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Marijuana Misdemeanor Expungement Bill (H.R. 8557). NCR has also supported comprehensive cannabis reform efforts as they develop in the Senate. NCR met with the White House on cannabis clemency issues, specifically pardons for non-violent offenders, a process for post-conviction release and calling for a reclassification of cannabis.
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
The National Cannabis Rountable supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. NCR's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA), America COMPETES bill, the end of year omnibus bill and other legislative vehicles. NCR also was active on the CLIMB Act (H.R. 8200), a bill that provides safe harbors for financial institutions, government programs, and capital markets. NCR discussed this concept with Senate offices but no Senate companion bill was introduced. NCR further discussed a SAFE "Plus" with House and Senate leadership which include language relating to expungements and provisions relating to firearm ownership for state authorized medical cannabis patients.
Medical Marijuana and Cannabidiol Research Expansion Act
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
Marijuana Misdemeanor Expungement Act
Client: NATIONAL CANNABIS ROUNDTABLE · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Marijuana Misdemeanor Expungement Bill (H.R. 8557). NCR has also supported comprehensive cannabis reform efforts as they develop in the Senate. NCR met with the White House on cannabis clemency issues, specifically pardons for non-violent offenders, a process for post-conviction release and calling for a reclassification of cannabis.
Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2025 · first_quarter · 1T
Focused on issues of debanking and the safe banking act in the cannabis industry
Focused on language protecting state-legal cannabis programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANNABIS FINNANCIAL INDUSTRY GROUP via THE LIAISON GROUP, LLC
2024 · fourth_quarter · Q4
Working to advance the SAFE Banking act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2024 · fourth_quarter · Q4
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
Ensuring cannabis businesses have access to financial services (SAFE Banking Act HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including what the Misdemeanor Expungement Act (H.R. 8917) last congress and the HOPE Act (S. 4161, HR 2677) Legislation which gives states autonomy to regulate cannabis and deschedules cannabis based on state law.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CANNABIS FINNANCIAL INDUSTRY GROUP via THE LIAISON GROUP, LLC
2024 · third_quarter · Q3
Working to advance the SAFE Banking act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANNABIS FINNANCIAL INDUSTRY GROUP via THE LIAISON GROUP, LLC
2024 · third_quarter · RR
Discussing the SAFE/R Banking Act and compliance best practices for financial institutions and service providers serving the state legal cannabis industry
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2024 · third_quarter · Q3
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2024 · second_quarter · Q2
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2024 · first_quarter · Q1
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including what was the Misdemeanor Expungement Act last congress and the HOPE Act from last congress. Active on the STATES Act 2.0 (HR 6673) which gives states autonomy to regulate cannabis and deschedules cannabis based on state law.
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2023 · fourth_quarter · Q4
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2023 · third_quarter · Q3
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions, The SAFER Banking Act S. 2860
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2023 · first_quarter · Q1
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Working on appropriations provisions that prevent the Department of Justice from interfering in state legal cannabis programs (both medical and adult use), allowing JAG Bryne funding to be used for expungements, banking language, various language proposals allowing veterans to access cannabis, fairness in federal drug testing, language protecting tribal sovereignty on cannabis decisions, and language promoting further research into cannabis.
NATIONAL CANNABIS ROUNDTABLE via THE LIAISON GROUP, LLC
2022 · fourth_quarter · Q4
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Marijuana Misdemeanor Expungement Bill (H.R. 8557). NCR has also supported comprehensive cannabis reform efforts as they develop in the Senate. NCR met with the White House on cannabis clemency issues, specifically pardons for non-violent offenders, a process for post-conviction release and calling for a reclassification of cannabis.
NCR supports the expansion of protections for the cannabis industry through the appropriations process, namely the expansion of medical protections to include adult use, increased veterans access, as well as the inclusion of SAFE Banking language in an appropriations amendment. NCR also supports the removal of the Harris Rider which prevents the District of Columbia from legalizing commercial cannabis sales. NCR also supports an appropriations provision that prevents the FCC from preventing broadcasters from advertising cannabis companies.
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including what the Misdemeanor Expungement Act (H.R. 8917) last congress and the HOPE Act (S. 4161, HR 2677) Legislation which gives states autonomy to regulate cannabis and deschedules cannabis based on state law.
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including what the Misdemeanor Expungement Act (H.R. 8917) last congress and the HOPE Act (S. 4161, HR 2677) STATES Act 2.0 (HR 6673) which gives states autonomy to regulate cannabis and deschedules cannabis based on state law.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Ensuring cannabis businesses have access to financial services (Congresses the SAFE Banking Ac HR 2891, S. 1323). discussion of broad access to financial institutions and capital, The SAFER Banking Act S. 2860
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including what was the Misdemeanor Expungement Act last congress and the HOPE Act from last congress. Active on the STATES Act 2.0 (HR 6673) which gives states autonomy to regulate cannabis and deschedules cannabis based on state law.
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including what was the Misdemeanor Expungement Act last congress and the HOPE Act from last congress.
Allowing District of Columbia to have autonomy on issues of creating a regulated cannabis marketplace
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Bills to reduce criminal penalties of cannabis possession and distribution, including but not limited to for bills that remove cannabis from the Schedules in the Controlled Substances Act. Also active on provisions that would facilitate expungements of cannabis offenses including the Misdemeanor Expungement Act and the HOPE Act.
Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and hemp-derived intoxicating products
Ensuring cannabis businesses have access to financial services (in former Congresses the SAFE Banking Act)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
The National Cannabis Rountable supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. NCR's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA), America COMPETES bill, the end of year omnibus bill and other legislative vehicles. NCR also was active on the CLIMB Act (H.R. 8200), a bill that provides safe harbors for financial institutions, government programs, and capital markets. NCR discussed this concept with Senate offices but no Senate companion bill was introduced. NCR further discussed a SAFE "Plus" with House and Senate leadership which include language relating to expungements and provisions relating to firearm ownership for state authorized medical cannabis patients.
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).
NCR discussed issue of the appropriateness of scheduling cannabis and its derivatives under the Controlled Substances Act, including ramifications of moving cannabis to a lower schedule (Schedules II-V), or removing from the list of controlled substances entirely. NCR expects to continue to weigh in on this policy consideration as it relates to medical utility and consumer safety as the Administration continues its review process.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office